+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ulcer relapse rates following initial treatment with bismuth subnitrate as compared with cimetidine respectively



Ulcer relapse rates following initial treatment with bismuth subnitrate as compared with cimetidine respectively



International Journal of Clinical Pharmacology, Therapy, and Toxicology 29(11): 437-440



As part of an open clinical trial, 18 out of 23 (78%) patients were treated with bismuth subnitrate (3 .times. 700 mg/d) and 15 out of 25 (60%) patients were treated with cimetidine (1 .times. 800 mg/d) to cure peptic ulcers linked with Helicobacter pylori, as ascertained following an endoscopic examination. All patients underwent continued observation after complete healing on completion of four weeks of acute treatment. In order to determine the effect of the initial treatment on the rate of relapse, all patients were asked to return for a check-up to establish any relapse, 6 and 12 months following completion of treatment. Gastroduodenoscopy was performed where a recurrent ulcer was suspected. An immediate control examination was carried out if acute symptoms occurred between the controls. In cases of suspected ulcer recurrence, and endoscopic examination was carried out and biopsy specimens were taken in order to detect H. pylori by biochemical and histological tests. In the bismuth group, three relapses (17%) were endoscopically verified 19 to 34 weeks after completion of treatment; 2 patients showed H. pylori positive results. Of the cimetidine group, 6 patients (35%) suffered a recurrent ulcer from the 9th to the 34th week following completion of the acute therapy. Five out of the six patients were H. pylori-positive. A comparison of relapse rates between the two groups was of no statistical significance. Compared with the initial H2 receptor antagonist treatment, there was a distinctly lower relapse rate in patients who were initially treated with bismuth subnitrate.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007977164

Download citation: RISBibTeXText

PMID: 1800390


Related references

Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate. Scandinavian Journal of Gastroenterology. Supplement 80: 39-42, 1982

Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate. Journal of Clinical Gastroenterology 3(Suppl 2): 163-165, 1981

A double-blind, endoscopically assessed evaluation of a bismuth subnitrate preparation (Roter) and cimetidine in the treatment of duodenal ulcer. British Journal of Clinical Practice 40(9): 373-375, 1986

Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine. Lancet 2(8404): 698, 1984

Relapse rates following initial ulcer healing with sucralfate and cimetidine. Scandinavian Journal of Gastroenterology. Supplement 83: 53-56, 1983

Relapse rates after initial ulcer healing with sucralfate and cimetidine. Scandinavian Journal of Gastroenterology 17(3): 429-432, 1982

Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole. Tidsskrift for den Norske Laegeforening 112(25): 3197-3199, 1992

Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate?. British Medical Journal 284(6316): 621-623, 1982

Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing. Digestion 23(2): 73-79, 1982

Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies). Terapevticheskii Arkhiv 63(2): 21-26, 1991

Relapse rates of duodenal ulcer healed with concentrated antacid or cimetidine. Hepato-Gastroenterology 31(6): 266-268, 1984

Alleviation of cisplatin toxicity by high-dose bismuth subnitrate and pharmacokinetics of bismuth subnitrate and cisplatin. Nihon Gan Chiryo Gakkai Shi 25(6): 1138-1145, 1990

Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial. Gastroenterologie Clinique et Biologique 9(2): 147-152, 1985

Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet 1(8210): 7-10, 1981

Controlled cimetidine treatment of duodenal ulcer compared with the traditional ulcer disease treatment. Lijecnicki Vjesnik 102(9): 517-521, 1980